Industry Research Reports
Home > Reports > Service & Software > Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-26
Pages: 146 Pages
Report ld: 6339613
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Biotech and Pharmaceutical Companies accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Cell and Gene Therapy Supply Chain Solution leading players (including Cencora, Inc（World Courier）, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, etc.), dominate supply; the top five capture approximately % of global revenue, with Cencora, Inc（World Courier） leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Cell and Gene Therapy Supply Chain Solution market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Cencora, Inc（World Courier）
- QuickStat
- Associated Couriers, LLC
- Central Pharma
- POLAR EXPRES
- Biocair
- time:matters
- Mercury Business Services
- Cardinal Health
- CRYOPDP
- Cryoport
- NMDP BioTherapies
- McKesson
- Excel Courier
- Almac
- BEAM Logistics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Courier Company Provided
- Hosted Logistics Company Provided
Segment by Application
- Biotech and Pharmaceutical Companies
- Hospitals
- Research Organizations
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Cell and Gene Therapy Supply Chain Solution study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cell and Gene Therapy Supply Chain Solution: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cell and Gene Therapy Supply Chain Solution Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Courier Company Provided
1.2.3 Hosted Logistics Company Provided
1.3 Market Segmentation by Application
1.3.1 Global Cell and Gene Therapy Supply Chain Solution Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Research Organizations
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cell and Gene Therapy Supply Chain Solution Revenue Estimates and Forecasts (2021-2032)
2.2 Global Cell and Gene Therapy Supply Chain Solution Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Cell and Gene Therapy Supply Chain Solution Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Cell and Gene Therapy Supply Chain Solution Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Courier Company Provided: Market Share by Key Players
3.3.2 Hosted Logistics Company Provided: Market Share by Key Players
3.4 Global Cell and Gene Therapy Supply Chain Solution Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Cell and Gene Therapy Supply Chain Solution Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Cell and Gene Therapy Supply Chain Solution Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Cell and Gene Therapy Supply Chain Solution Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Cell and Gene Therapy Supply Chain Solution Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Cell and Gene Therapy Supply Chain Solution Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Cell and Gene Therapy Supply Chain Solution Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Cencora, Inc（World Courier）
11.1.1 Cencora, Inc（World Courier） Corporation Information
11.1.2 Cencora, Inc（World Courier） Business Overview
11.1.3 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.1.4 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.1.5 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Revenue by Product in 2025
11.1.6 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Revenue by Application in 2025
11.1.7 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Revenue by Geographic Area in 2025
11.1.8 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution SWOT Analysis
11.1.9 Cencora, Inc（World Courier） Recent Developments
11.2 QuickStat
11.2.1 QuickStat Corporation Information
11.2.2 QuickStat Business Overview
11.2.3 QuickStat Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.2.4 QuickStat Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.2.5 QuickStat Cell and Gene Therapy Supply Chain Solution Revenue by Product in 2025
11.2.6 QuickStat Cell and Gene Therapy Supply Chain Solution Revenue by Application in 2025
11.2.7 QuickStat Cell and Gene Therapy Supply Chain Solution Revenue by Geographic Area in 2025
11.2.8 QuickStat Cell and Gene Therapy Supply Chain Solution SWOT Analysis
11.2.9 QuickStat Recent Developments
11.3 Associated Couriers, LLC
11.3.1 Associated Couriers, LLC Corporation Information
11.3.2 Associated Couriers, LLC Business Overview
11.3.3 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.3.4 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.3.5 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Revenue by Product in 2025
11.3.6 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Revenue by Application in 2025
11.3.7 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Revenue by Geographic Area in 2025
11.3.8 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution SWOT Analysis
11.3.9 Associated Couriers, LLC Recent Developments
11.4 Central Pharma
11.4.1 Central Pharma Corporation Information
11.4.2 Central Pharma Business Overview
11.4.3 Central Pharma Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.4.4 Central Pharma Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.4.5 Central Pharma Cell and Gene Therapy Supply Chain Solution Revenue by Product in 2025
11.4.6 Central Pharma Cell and Gene Therapy Supply Chain Solution Revenue by Application in 2025
11.4.7 Central Pharma Cell and Gene Therapy Supply Chain Solution Revenue by Geographic Area in 2025
11.4.8 Central Pharma Cell and Gene Therapy Supply Chain Solution SWOT Analysis
11.4.9 Central Pharma Recent Developments
11.5 POLAR EXPRES
11.5.1 POLAR EXPRES Corporation Information
11.5.2 POLAR EXPRES Business Overview
11.5.3 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.5.4 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.5.5 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Revenue by Product in 2025
11.5.6 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Revenue by Application in 2025
11.5.7 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Revenue by Geographic Area in 2025
11.5.8 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution SWOT Analysis
11.5.9 POLAR EXPRES Recent Developments
11.6 Biocair
11.6.1 Biocair Corporation Information
11.6.2 Biocair Business Overview
11.6.3 Biocair Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.6.4 Biocair Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.6.5 Biocair Recent Developments
11.7 time:matters
11.7.1 time:matters Corporation Information
11.7.2 time:matters Business Overview
11.7.3 time:matters Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.7.4 time:matters Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.7.5 time:matters Recent Developments
11.8 Mercury Business Services
11.8.1 Mercury Business Services Corporation Information
11.8.2 Mercury Business Services Business Overview
11.8.3 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.8.4 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.8.5 Mercury Business Services Recent Developments
11.9 Cardinal Health
11.9.1 Cardinal Health Corporation Information
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.9.4 Cardinal Health Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.9.5 Cardinal Health Recent Developments
11.10 CRYOPDP
11.10.1 CRYOPDP Corporation Information
11.10.2 CRYOPDP Business Overview
11.10.3 CRYOPDP Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.10.4 CRYOPDP Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Cryoport
11.11.1 Cryoport Corporation Information
11.11.2 Cryoport Business Overview
11.11.3 Cryoport Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.11.4 Cryoport Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.11.5 Cryoport Recent Developments
11.12 NMDP BioTherapies
11.12.1 NMDP BioTherapies Corporation Information
11.12.2 NMDP BioTherapies Business Overview
11.12.3 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.12.4 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.12.5 NMDP BioTherapies Recent Developments
11.13 McKesson
11.13.1 McKesson Corporation Information
11.13.2 McKesson Business Overview
11.13.3 McKesson Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.13.4 McKesson Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.13.5 McKesson Recent Developments
11.14 Excel Courier
11.14.1 Excel Courier Corporation Information
11.14.2 Excel Courier Business Overview
11.14.3 Excel Courier Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.14.4 Excel Courier Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.14.5 Excel Courier Recent Developments
11.15 Almac
11.15.1 Almac Corporation Information
11.15.2 Almac Business Overview
11.15.3 Almac Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.15.4 Almac Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.15.5 Almac Recent Developments
11.16 BEAM Logistics
11.16.1 BEAM Logistics Corporation Information
11.16.2 BEAM Logistics Business Overview
11.16.3 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Product Features and Attributes
11.16.4 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Revenue and Gross Margin (2021-2026)
11.16.5 BEAM Logistics Recent Developments
12 Cell and Gene Therapy Supply Chain Solution Value Chain and Ecosystem Analysis
12.1 Cell and Gene Therapy Supply Chain Solution Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cell and Gene Therapy Supply Chain Solution Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cell and Gene Therapy Supply Chain Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Cell and Gene Therapy Supply Chain Solution Revenue by Region (US$ Million), 2021-2026
Table 5. Global Cell and Gene Therapy Supply Chain Solution Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Cell and Gene Therapy Supply Chain Solution Revenue by Players (US$ Million), 2021-2026
Table 8. Global Cell and Gene Therapy Supply Chain Solution Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Cell and Gene Therapy Supply Chain Solution Revenue, 2025
Table 11. Global Cell and Gene Therapy Supply Chain Solution Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Cell and Gene Therapy Supply Chain Solution Companies Headquarters
Table 13. Global Cell and Gene Therapy Supply Chain Solution Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cell and Gene Therapy Supply Chain Solution Revenue by Type (US$ Million), 2021-2026
Table 17. Global Cell and Gene Therapy Supply Chain Solution Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cell and Gene Therapy Supply Chain Solution Revenue by Application (US$ Million), 2021-2026
Table 20. Global Cell and Gene Therapy Supply Chain Solution Revenue by Application (US$ Million), 2027-2032
Table 21. Cell and Gene Therapy Supply Chain Solution High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cell and Gene Therapy Supply Chain Solution Growth Accelerators and Market Barriers
Table 25. North America Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Cell and Gene Therapy Supply Chain Solution Growth Accelerators and Market Barriers
Table 27. Europe Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Cell and Gene Therapy Supply Chain Solution Investment Opportunities and Key Challenges
Table 31. Central and South America Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Cell and Gene Therapy Supply Chain Solution Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cell and Gene Therapy Supply Chain Solution Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Cencora, Inc（World Courier） Corporation Information
Table 35. Cencora, Inc（World Courier） Description and Major Businesses
Table 36. Cencora, Inc（World Courier） Product Features and Attributes
Table 37. Cencora, Inc（World Courier） Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Cencora, Inc（World Courier） Revenue Proportion by Product in 2025
Table 39. Cencora, Inc（World Courier） Revenue Proportion by Application in 2025
Table 40. Cencora, Inc（World Courier） Revenue Proportion by Geographic Area in 2025
Table 41. Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution SWOT Analysis
Table 42. Cencora, Inc（World Courier） Recent Developments
Table 43. QuickStat Corporation Information
Table 44. QuickStat Description and Major Businesses
Table 45. QuickStat Product Features and Attributes
Table 46. QuickStat Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. QuickStat Revenue Proportion by Product in 2025
Table 48. QuickStat Revenue Proportion by Application in 2025
Table 49. QuickStat Revenue Proportion by Geographic Area in 2025
Table 50. QuickStat Cell and Gene Therapy Supply Chain Solution SWOT Analysis
Table 51. QuickStat Recent Developments
Table 52. Associated Couriers, LLC Corporation Information
Table 53. Associated Couriers, LLC Description and Major Businesses
Table 54. Associated Couriers, LLC Product Features and Attributes
Table 55. Associated Couriers, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Associated Couriers, LLC Revenue Proportion by Product in 2025
Table 57. Associated Couriers, LLC Revenue Proportion by Application in 2025
Table 58. Associated Couriers, LLC Revenue Proportion by Geographic Area in 2025
Table 59. Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution SWOT Analysis
Table 60. Associated Couriers, LLC Recent Developments
Table 61. Central Pharma Corporation Information
Table 62. Central Pharma Description and Major Businesses
Table 63. Central Pharma Product Features and Attributes
Table 64. Central Pharma Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Central Pharma Revenue Proportion by Product in 2025
Table 66. Central Pharma Revenue Proportion by Application in 2025
Table 67. Central Pharma Revenue Proportion by Geographic Area in 2025
Table 68. Central Pharma Cell and Gene Therapy Supply Chain Solution SWOT Analysis
Table 69. Central Pharma Recent Developments
Table 70. POLAR EXPRES Corporation Information
Table 71. POLAR EXPRES Description and Major Businesses
Table 72. POLAR EXPRES Product Features and Attributes
Table 73. POLAR EXPRES Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. POLAR EXPRES Revenue Proportion by Product in 2025
Table 75. POLAR EXPRES Revenue Proportion by Application in 2025
Table 76. POLAR EXPRES Revenue Proportion by Geographic Area in 2025
Table 77. POLAR EXPRES Cell and Gene Therapy Supply Chain Solution SWOT Analysis
Table 78. POLAR EXPRES Recent Developments
Table 79. Biocair Corporation Information
Table 80. Biocair Description and Major Businesses
Table 81. Biocair Product Features and Attributes
Table 82. Biocair Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Biocair Recent Developments
Table 84. time:matters Corporation Information
Table 85. time:matters Description and Major Businesses
Table 86. time:matters Product Features and Attributes
Table 87. time:matters Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. time:matters Recent Developments
Table 89. Mercury Business Services Corporation Information
Table 90. Mercury Business Services Description and Major Businesses
Table 91. Mercury Business Services Product Features and Attributes
Table 92. Mercury Business Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Mercury Business Services Recent Developments
Table 94. Cardinal Health Corporation Information
Table 95. Cardinal Health Description and Major Businesses
Table 96. Cardinal Health Product Features and Attributes
Table 97. Cardinal Health Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Cardinal Health Recent Developments
Table 99. CRYOPDP Corporation Information
Table 100. CRYOPDP Description and Major Businesses
Table 101. CRYOPDP Product Features and Attributes
Table 102. CRYOPDP Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. CRYOPDP Recent Developments
Table 104. Cryoport Corporation Information
Table 105. Cryoport Description and Major Businesses
Table 106. Cryoport Product Features and Attributes
Table 107. Cryoport Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Cryoport Recent Developments
Table 109. NMDP BioTherapies Corporation Information
Table 110. NMDP BioTherapies Description and Major Businesses
Table 111. NMDP BioTherapies Product Features and Attributes
Table 112. NMDP BioTherapies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. NMDP BioTherapies Recent Developments
Table 114. McKesson Corporation Information
Table 115. McKesson Description and Major Businesses
Table 116. McKesson Product Features and Attributes
Table 117. McKesson Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. McKesson Recent Developments
Table 119. Excel Courier Corporation Information
Table 120. Excel Courier Description and Major Businesses
Table 121. Excel Courier Product Features and Attributes
Table 122. Excel Courier Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Excel Courier Recent Developments
Table 124. Almac Corporation Information
Table 125. Almac Description and Major Businesses
Table 126. Almac Product Features and Attributes
Table 127. Almac Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Almac Recent Developments
Table 129. BEAM Logistics Corporation Information
Table 130. BEAM Logistics Description and Major Businesses
Table 131. BEAM Logistics Product Features and Attributes
Table 132. BEAM Logistics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. BEAM Logistics Recent Developments
Table 134. Technologies, Platforms and Infrastructure
Table 135. Distributors List
Table 136. Market Trends and Market Evolution
Table 137. Market Drivers and Opportunities
Table 138. Market Challenges, Risks, and Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Courier Company Provided Product Picture
Figure 3. Hosted Logistics Company Provided Product Picture
Figure 4. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 5. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Biotech and Pharmaceutical Companies
Figure 7. Hospitals
Figure 8. Research Organizations
Figure 9. Other
Figure 10. Cell and Gene Therapy Supply Chain Solution Report Years Considered
Figure 11. Global Cell and Gene Therapy Supply Chain Solution Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 13. Global Cell and Gene Therapy Supply Chain Solution Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Cell and Gene Therapy Supply Chain Solution Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Cell and Gene Therapy Supply Chain Solution Revenue-Based Market Share Ranking (2025)
Figure 16. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 17. Courier Company Provided Revenue-Based Market Share by Player in 2025
Figure 18. Hosted Logistics Company Provided Revenue-Based Market Share by Player in 2025
Figure 19. Global Cell and Gene Therapy Supply Chain Solution Revenue-Based Market Share by Type (2021-2032)
Figure 20. Global Cell and Gene Therapy Supply Chain Solution Revenue-Based Market Share by Application (2021-2032)
Figure 21. North America Cell and Gene Therapy Supply Chain Solution Revenue YoY (US$ Million), 2021-2032
Figure 22. North America Top 5 Players Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) in 2025
Figure 23. North America Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) by Application (2021-2032)
Figure 24. US Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 25. Canada Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 26. Mexico Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 27. Europe Cell and Gene Therapy Supply Chain Solution Revenue YoY (US$ Million), 2021-2032
Figure 28. Europe Top 5 Players Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) in 2025
Figure 29. Europe Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) by Application (2021-2032)
Figure 30. Germany Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 31. France Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 32. U.K. Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 33. Italy Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 34. Russia Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 35. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue YoY (US$ Million), 2021-2032
Figure 36. Asia-Pacific Top 8 Players Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) in 2025
Figure 37. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) by Application (2021-2032)
Figure 38. Indonesia Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 39. Japan Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 40. South Korea Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 41. Australia Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 42. India Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 43. Indonesia Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 44. Vietnam Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 45. Malaysia Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 46. Philippines Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 47. Singapore Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 48. Central and South America Cell and Gene Therapy Supply Chain Solution Revenue YoY (US$ Million), 2021-2032
Figure 49. Central and South America Top 5 Players Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) in 2025
Figure 50. Central and South America Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) by Application (2021-2032)
Figure 51. Brazil Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 52. Argentina Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 53. Middle East and Africa Cell and Gene Therapy Supply Chain Solution Revenue YoY (US$ Million), 2021-2032
Figure 54. Middle East and Africa Top 5 Players Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) in 2025
Figure 55. Middle East and Africa Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) by Application (2021-2032)
Figure 56. GCC Countries Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 57. Israel Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 58. Egypt Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 59. South Africa Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million), 2021-2032
Figure 60. Cell and Gene Therapy Supply Chain Solution Value Chain Mapping
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cell and Gene Therapy Supply Chain Solution market?
The top companies in the global Cell and Gene Therapy Supply Chain Solution market are Cencora, Inc（World Courier）、QuickStat、Associated Couriers, LLC.
Related Reports
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 107
USD 4250.00
(Single User License)
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 130
USD 3950.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 130
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 105
USD 4250.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 155
USD 4900.00
(Single User License)
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 129
USD 3950.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 91
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-12
Pages: 93
USD 2900.00
(Single User License)
Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-12
Pages: 128
USD 4350.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-12
Pages: 156
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 107
USD 4250.00 (Single User License)Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 130
USD 3950.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 130
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 105
USD 4250.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 155
USD 4900.00 (Single User License)Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 129
USD 3950.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 91
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-12
Pages: 93
USD 2900.00 (Single User License)Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-12
Pages: 128
USD 4350.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-12
Pages: 156
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now